FOLIA HISTOCHEMICA
ET CYTOBIOLOGICA
Vol. 43, No. 1, 2005
pp. 25-30
Generation of dendritic cells from human peripheral blood monocytes - comparison of different culture media
Nataliya Tkachenko, Kamila Wojas, Jacek Tabarkiewicz and Jacek Rolinski Department of Clinical Immunology, Medical University, Lublin, Poland
Abstract: Culture medium or medium supplement is one of the factors responsible for dendritic cell (DC) generation, but little is known about the influence of various media on DC culture. In our study we generated DC from adherent monocytes of human peripheral blood in the prence of GM-CSF, IL-4 and TNF-α. The following culture media were ud: RPMI 1640 supplemented with 2% human rum albumin; RPMI 1640 supplemented with 2% TCH rum replacement; X-VIVO 15 and Panrin 501. Flow cytometry analysis revealed that in all media cells were CD83+ and lost CD14. Interestingly, the u
of Panrin and RPMI with albumin preferentially gave ri to CD1a+ DC, whereas in X-VIVO and RPMI with TCH we obrved both CD1a+ and CD1a-. Our results showed that RPMI with TCH yielded the highest percentage of cells expressing both CD80 and CD86 molecules and, in contrast to other media, the higher percentage of CD86+ cells in comparison to CD80+ cells.
Key words: Dendritic cells - Serum-free medium - Cell culture
Introduction
Dendritic cells (DC) are the most potent antigen prenting cells that play a pivotal role in the immune respon by processing and prenting antigens to T-cells [2, 9]. Fol-lowing the discovery of methods to generate large numbers of DC ex vivo, the u of DC as effective adjuvants for cancer treatment was demonstrated in clinical studies [8, 13, 15]. The interest of recent investigations is focud on the development of DC-bad immunotherapy of human malignant dias [22, 28]. So, there is a demand to establish reproducible and efficient methods to gener-ate adequate number of fully functional DC for clinical applications. For the first time, human DC were cultured from CD34+ haematopoietic progenitors in the prence of granulocyte-macrophage colony stimulating factor (GM-CSF) and tumor necrosis factor alpha (TNF-α) [5]. Then it was reported that DC can also be ge
nerated from nonproliferating CD14+ monocytes of human periphe-ral blood by cultivation with GM-CSF, IL-4 and matur-ation stimuli such as monocyte-conditioned medium (MCM), TNF-α, CD40L and PGE2 [3, 17-19, 20, 26, 27, 29]. Some studies demonstrated DC culturing from cord blood CD34+ cells and monocytes [12, 30].
The method of DC generation from peripheral blood monocytes is widespread in experimental and clinical studies. It allows to obtain large numbers of monocyte-derived DC without pretreatment of donors with any cytokines to mobilize CD34+ stem cells from the bone marrow into the peripheral blood [18]. The DC obtained by this approach are mature and stable which is prefer-able for the purpo of immunotherapy [18, 26]. More-over, this method gives a possibility to generate DC without involving xenologous proteins such as fetal calf rum (FCS), which can be potentially infective and immunogenic [3, 18]. Although the protocols for DC culturing have been developed, they are still not stand-ardized and need further improvements for clinical u. It has been shown that generation of monocyte-derived DC is not only dependent on certain cytokines [24], but also on culture media and supplements [1, 7, 14, 16, 26]. However, little is known about the role of culture media in DC cultivation. The aim of the prent study was to investigate the influence of different culture media on generation of DC from peripheral blood mononuclear cells (PBMC).
Materials and methods
Isolation of peripheral blood mononuclear cells (PBMC). Periph-eral blood (50-100 ml) was obtained from 10 healthy volunteers by venous puncture and collected in sterile heparinized tubes. The blood was diluted 1:1 with phosphate buffered saline (PBS) without Ca2+
Correspondence: N. Tkachenko, Dept. Clinical Immunology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland; e-mail:
and Mg2+ (ud in all following experiments). PBMC were isolated by centrifugation in density gradient (Gradisol L, Aqua Medica, Poland) and washed twice in PBS before being resuspended in the appropriate assay medium.
Generation of monocyte-derived DC. PBMC were plated in 6-well tissue culture dishes (Greiner, Germany) at a density of 2 × 106 cells/ml. Four culture media were ud: RPMI 1640 (PAN Biotech GmbH, Germany) supplemented with 2% human rum albumin (Bioplasma AG, Switzerland), which we ud in the standard proce-dure; RPMI 1640 containing 2% TCH rum replacement (ICN Biomedicals, USA); X-VIVO 15 rum-free medium (Biowittaker, Walkersville, MD, USA); Panrin 501 with L-glutamine (PAN Biotech GmbH, Germany). All media were supplemented with peni-cillin (
50 IU/ml), streptomycin (0.05 mg/ml) and neomycin (0.1 mg/ml) (Sigma, Germany). Mononuclear cells were incubated at 37˚C and 5% CO2 for 90 min for monocyte adherence. After the incubation period, the non-adherent cells were removed by washing twice with the respective medium; the cell culture dishes were filled with cold PBS for 20 min at 4˚C and then finally washed with cold PBS. The adherent cells were cultured in the respective medium containing GM-CSF (1000 IU/ml, Leukomax Novartis, Switzerland) and IL-4 (500 IU/ml, Strathmann Biotec AG, Germany). Cytokines in the same dosages were added again on days 3 and 5; culture medium was not changed. The maturation of DC was induced by addition of TNF-α (50 ng/ml, Strathmann Biotec AG, Germany) on day 6. On day 8 cells were harvested and ud for subquent experiments.
Cell staining. Immunofluorescent staining was performed according to manufacturer’s protocols. Cells were stained with the following directly conjugated monoclonal antibodies (MoAbs) in the following combinations: mou isotype control IgG1/IgG2A/IgG2A FITC/PE/TC, CD45/CD14 FITC/PE, CD83/CD1a/HLA-DR FITC/PE/CyChrome, CD80/CD86/HLA-DR FITC/PE/CyChrome (HLA-DR from Pharmingen, USA; other MoAbs from Caltag, Bur-Fig. 1. Gating of dendritic cells (R1) and residual lymphocytes (R2). Fig. 2. Expression of surface markers: CD14 (a), CD83 (b), CD1a (c), CD80 (d) and CD86 (e) on dendritic cells generated in different culture media. X-axis shows fluorescence intensity, Y-axis - cell number.
26N. Tkachenko et al.
R2
R1
12a
2c 2b
2e 2d
lingame, CA, USA). In brief, after culturing cells were collected, washed with PBS and incubated with
MoAbs for 30 min at 4˚C. To minimize FcR-mediated MoAb binding, cells were stained in the prence of FcR-blocking reagent (Miltenyi Biotec, Germany). Flow cytometry. Cells were analyd by three-color flow cytometry technique using Becton Dickinson FACSCalibur, equipped with 488 nm argon lar. A minimum of 30 000 events were acquired and analyd by CellQuest Software.
Statistical analysis. The nonparametric Wilcoxon matched pair signed rank test was applied. Differences were considered as statis-tically significant at p≤0.05.
Results
After culturing, all media gave comparable DC number (79.44%±10.98 in RPMI with albumin, 70.74%±12.04 in RPMI with TCH, 77.56%±14.08 in X-VIVO, 72.74%±22.56 in Panrin), with a significant difference between albumin- and TCH- containing media. The per-centage of residual lymphocytes did not differ significantly between the media (7.61%±5.21 in RPMI supplemented with albumin, 10.19%±4.58 in RPMI with TCH, 11.49%±9.16 in X-VIVO 15 and 7.34%±5.17 in Panrin).
Analysis of surface markers expression of cultured cells is shown in a reprentative experiment (Fig. 1). The immunophenotypic characteristics of generated cells is prented in Table 1.
We found that all media led to the loss of monocyte surface marker CD14. There was also no significant difference in the percentage of cells expressing CD83 molecule, a marker of mature DC. The percentage of cells expressing CD1a, a marker of immature DC, was the lowest in RPMI with TCH, and it significantly dif-fered from X-VIVO and Panrin.
We noticed a significant difference in the percentage of cells with fully mature DC phenotype (83+1a-) be-tween RPMI with albumin and RPMI with TCH as well as between X-VIVO and Panrin. The percentage of cells with partially mature DC phenotype (83+1a+) was the highest in Panrin and the lowest in TCH-contain-ing RPMI, with a significant difference between the media. Comparison of fully mature and partially mature DC showed that their percentages did not differ signifi-cantly in RPMI with TCH as well as in X-VIVO. The percentage of 83+1a+ cells was significantly higher in comparison to 83+1a- cells in albumin-containing me-dium and Panrin.
Our findings showed that RPMI with TCH yielded the highest percentage of cells expressing both CD80 and CD86 costimulatory molecules, and it significantly dif-fered from X-VIVO and Panrin. Comparison of CD80+ and CD86+ cells demonstrated that the percentage of CD86+ cells was significantly higher than percentage of CD80+ cells in RPMI with TCH, while there was no significant difference between the cells in other media. Discussion
Growth and maturation of DC in culture can be in-fluenced by a variety of factors. One of them has been shown to be culture medium or medium supplement.
Table 1. Immunophenotypes of cells cultured in different culture media
Cell surface immunophenotype (CD)
Percentages of cells in the studied culture media
RPMI 1640 with
2% albumin
RPMI 1640 with
2% TCH
X-VIVO 15Panrin 501
45+14-
87.64
77.45-95.34
80.65
71.89-86.18
84.58
67.76-94.37
83.44
79.60-94.39
83+
37.29
26.95-47.56
55.41
16.28-68.45
48.10
35.53-66.07
61.31
45.11-64.47
1a+
28.63
13.96-55.19
23.52
8.98-37.59
38.43b
29.54-48.37
43.17c
33.31-64.07
83+1a+
22.34
11.20-32.70
17.96
8.55-34.88
28.22
20.33-37.47
40.37c
31.33-57.47
83+1a-
7.04a
2.12-14.86
13.70香菇豆腐汤的做法
8.19-40.15
15.78d
3.85-37.38
9.06
5.36-30.96
80+
蒸饺怎么包70.40
44.09-83.94
80.05
60.34-91.58
56.21b
33.88-72.11
59.99c
44.28-61.16
86+
73.63a
45.51-83.75
87.12
烟火歌词
78.37-93.67
55.88b
37.61-71.94
58.67c
44.03-77.56
80+86+
67.73
42.97-82.23
79.50
59.42-90.97
49.75b
33.58-71.86
57.23c
43.58-60.93
Results are expresd as medians and 25th-75th percentiles of 10 experiments. Significant difference (p≤0.05) between: a RPMI with al-bumin and RPMI with TCH, b X-VIVO 15 and RPMI with TCH, c Panrin and RPMI with TCH, d X-VIVO 15 and Panrin.
Human dendritic cells in culture27
The generation of DC was described in media sup-plemented with FCS, human plasma or rum [1, 7, 16, 18]. For immunotheraupetic purpos it is desirable to avoid FCS becau its potential immunogenicity. Serum or plasma contain growth factors or other substances, which may influence the generation of DC, so it is necessary to determine the appropriate concentration of autologous plasma or rum in DC generation for each patient. For rum-free cultures, X-VIVO, AIM-V and RPMI 1640 were ud [7, 14, 18, 26, 27], also human albumin as protein component [1, 25]. Howev
er, the literature on the effects of different media on monocyte-derived DC generation is scarce.
In our study we investigated the influence of RPMI 1640 supplemented with 2% albumin, RPMI 1640 sup-plemented with 2% TCH, X-VIVO 15, and Panrin 501 on differentiation of DC from monocytes, with respect to their phenotype. All the media are rum-free and can be ud for mammalian cell cultivation. The u of medium supplemented with TCH and Panrin for DC generation has not yet been described.
The number of cultured DC is one of important characteristics of DC generation. Such medium supple-ments as autologous plasma or rum, human rum and fetal calf rum had no influence on DC yields [7, 14]. Also it has been shown that there is no difference be-tween RPMI 1640 and X-VIVO media in DC yields [7, 26]. In our experiment, all media gave comparable DC number. Nevertheless, the number of DC obtained in RPMI 1640 with albumin was significantly higher than in RPMI with TCH. Araki et al. obrved that DC number in culture with 2% albumin was consistently higher than in cultures with autologous plasma or rum [1].
The morphological appearance of DC generated in X-VIVO was similar to that of cells cultured in RPMI supplemented with albumin: during the culture cells detached from plastic dishes and formed
aggregates consisting of dendritic-like cells. However, X-VIVO contained smaller DC aggregates and occasional fibro-blastic cells. In Panrin and RPMI with TCH we ob-rved less cells with dendritic morphology, accompanied by fibroblast-like cells adherent to the culture plates. TCH-containing medium was found to have the strongest tendency to yield fibroblastic cells (data not shown).
Our experiments showed that cells obtained in differ-ent media displayed characteristic features of DC: they lost CD14, monocyte surface marker, and expresd CD83 molecule. CD83 is a typical marker of maturation on human DC [18, 31].
CD1a is expresd on Langerhans cells but periphe-ral blood DC never express it [9, 21]. It was also shown that during culture with GM-CSF and IL-4, monocytes differentiate into CD1a+ DC with further decread CD1a expression after maturation [18, 32] . We noticed that DC cultured in X-VIVO 15 and RPMI with TCH consisted of quantitatively almost equal populations of CD1a+ and CD1a- cells, whereas RPMI supplemented with albumin and Panrin preferentially led to the generation of CD1a+ DC. In contrast to our data, some studies demonstrated that X-VIVO resulted in rather homogenous populations of mature DC, but the results were controversial. Thurner et al. reported that the u of X-VIVO 15 gave ri to CD1a- DC [26]. Other authors obrved CD1a-positive DC generated in X-VIVO [7, 14, 30]. Interestingly, it was noticed that culture media with such supplemen
ts as autologous plas-ma or rum resulted in CD1a- and CD1a+ DC, whereas DC obtained in rum-free media mostly had high up-regulation of that marker [1, 7, 14, 16].
Our obrvation concerning albumin-supplemented RPMI is in agreement with results of Araki et al. who showed that monocytes differentiated into CD1a+ popu-lation in 2% albumin-supplemented culture [1]. The authors also noticed that DC obtained in albumin-con-taining medium were effective in phagocytic activity, similarly to DC generated in cultures with autologous plasma or rum. Although CD1a molecule is con-sidered to be a specific marker of immature DC [9, 21], Thurner et al. found that fully mature DC generated in RPMI 1640 still expresd CD1a molecules [26]. Simi-larly, another investigation demonstrated that during DC generation from peripheral and cord blood monocytes in X-VIVO 15 medium even after addition of TNF-α, CD1a+ was further up-regulated in mature DC [30].
CD1a belongs to CD1 family of antigen prenting molecules that are responsible for prenting lipid and glycolipid antigens to T cells [4, 10, 23]. Thus, express-ion of CD1a+ on DC may be significant in creating non-peptide vaccines.
CD80 and CD86 are characteristic of mature DC. The costimulatory molecules initiate and stabiliz
e DC interaction with T-cells through the corresponding li-gands [2, 9]. In our study, the number of cells expressing both CD80 and CD86 was the highest in RPMI sup-plemented with TCH.
The expression of CD80 and CD86 molecules and their role are likely dependent on DC precursors [6, 30]. The data on the influence of medium or culture supple-ments on expression of CD80 or CD86 are controversial. Vries et al. reported that DC generated from monocytes of melanoma patients in AIM-V, X-VIVO 15 and RPMI 1640 media supplemented with human rum had com-parable expression levels of costimulatory molecules [27]. In contrast to the findings, Duperrier et al. found that generation in human rum or autologous plasma resulted in higher number of DC with up-regulated CD86 expression in comparison with X-VIVO or FCS-supplemented media [7]. Describing DC generation in human plasma and FCS, Pietschmann et al. showed that FCS-derived DC had higher CD80 expression, while in
洗碗碟的英文28N. Tkachenko et al.
human plasma DC exhibited more mature profile and higher expression of CD86 [16]. Interestingly, we ob-rved higher percentage of CD86-positive cells in RPMI with TCH, while there was no difference between cells expressing costimulatory molecules in other media. Different expression of
CD80 and CD86 molecules in various culture media may be connected with the com-pensation of each other in costimulatory functions, which is supported by the fact that CD80 and CD86 provide similar costimulatory signals in T-cell respon [11], but further investigations are needed for under-standing of such influences.
We believe that our findings demonstrate the signi-ficance of culture medium role in DC generation from peripheral blood monocytes and will facilitate to work out a reproducible method that will be the most suitable for experimental and clinical applications. Acknowledgments: X-VIVO 15 medium was a generous gift from Biokom, Poland, TCH was supported by ICN, Poland and Panrin 501 from Cytogen, Poland.
References
[1] Araki H, Katayama N, Mitani H, Suzuki H, Nishikawa H,
Masuya M, Ikuta Y, Hoshino N, Miyashita H, Nishii K, Minami N, Shiku H (2001) Efficient ex vivo generation of dendritic cells from CD14+ blood monocytes in the prence of human rum albumin for u in clinical vaccine trials. Br J Haematol 114: 681-689
[2] Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y,
Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811
[3] Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N
(1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196: 121-135
[4] Cao X, Sugita M, Van Der Wel N, Lai J, Rogers RA, Peters PJ,
Brenner MB (2002) CD1 molecules efficiently prent antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J Immunol 169: 4770-4777
[5] Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J
(1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360: 258-261
[6] Dilioglou S, Cru JM, Lewis RE. Function of CD80 and CD86
on monocyte- and stem cell-derived dendritic cells (2003) Exp Mol Pathol 75: 217-227
[7] Duperrier K, Eljaafari A, Dezutter-Dambuyant C, Bardin C,
Jacquet C, Yoneda K, Schmitt D, Gebuhrer L, Rigal D (2000) Distinct subts of dendritic cells rembling dermal DCs can be generated in vitro from monocytes, in the prence of differ-ent rum supplements. J Immunol Methods 238: 119-131 [8] Fong L, Brockstedt D, Benike C, Wu L, Engleman EG (2001)
Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol 166: 4254-4259
[9] Hart DN (1997) Dendritic cells: unique leukocyte populations
which control the primary immune respon. Blood 90: 3245-3285
[10] Jullien D, Stenger S, Ernst WA, Modlin RL (1997) CD1 pres-
entation of microbial nonpeptide antigens to T cells. J Clin Invest 99: 2071-2074
[11] Lanier LL, O’Fallon S, Somoza C, Phillips JH, Linsley PS,
Okumura K, Ito D, Azuma M (1995) CD80 (B7) and CD86
(B70) provide similar costimulatory signals for T cell prolifera-tion, cytokine production, and generation of CTL. J Immunol 154: 97-105
[12] Liu A, Takahashi M, Narita M, Zheng Z, Kanazawa N, Abe T,
Nikkuni K, Furukawa T, Toba K, Fu I, Aizawa Y (2002) Generation of functional and mature dendritic cells from cord and bone marrow CD34+ cells by two-step culture combined calcium ionophore treatment. J Immunol Methods 261: 49-63 [13] Lodge PA, Jones LA, Bader RA, Murphy, GP, Salgaller ML
(2000) Dendritic cell-bad immunotherapy of prostate cancer: immune monitoring of a pha II clinical trial. Cancer Res 60: 829-833
[14] Loudovaris M, Hann M, Suen Y, Lee SM, Casing P, Bender
JG (2001) Differential effects of autologous rum on CD34+ or monocyte-derived dendritic cells. J Hematother Stem Cell Res 10: 569-578
[15] Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R,
Burg G, Schadendorf D (1998) Vaccination of melanoma pa-tients with peptide- or tumor lysate-puld dendritic cells. Nat Med 4: 328-332
[16] Pietschmann P, Stockl J, Draxler S, Majdic O, Knapp W (2000)
中班剪纸教案
Functional and phenotypic characteristics of dendritic cells generated in human plasma supplemented medium. Scand J Immunol 51: 377-383
[17] Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trocken-
bacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G (1994) Proliferating dendritic cell progenitors in human blood.
J Exp Med 180: 83-93
[18] Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B,
Niederwier D, Schuler G (1996) Generation of mature den-dritic cells from human blood - an improved method with special regard to clinical applicability. J Immunol Methods 196: 137-151 [19] Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N
男生眉毛
(1997) A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 90: 3640-3646
[20] Sallusto F, Lanzavecchia A (1994) Efficient prentation of
soluble antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus in-terleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179: 1109-1118
[21] Satthaporn S, Eremin O (2001) Dendritic cells (I): biological
function. J R Coll Surg Edinb 46: 9-20
[22] Steinmann RM, Pope M (2002) Exploiting dendritic cells to
improve vaccine efficacy. J Clin Invest 109: 1519-1526 [23] Sugita M, van Der Wel N, Rogers RA, Peters PJ, Brenner MB
(2000) CD1c molecules broadly survey the endocytic system.
Proc Natl Acad Sci USA 18: 8445-8450
[24] Syme R, Gluck S (2001) Effects on the culture and differentia-
tion of dendritic cells in vitro. J Hematother Stem Cell Res 10: 43-51
[25] Tarte K, Fiol G, Rossi JF, Klein B (2000) Extensive charac-
terization of dendritic cells generated in rum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell pha-gocytosis, chemotaxis and T cell activation during maturation in vitro. Leukemia 14: 2182-2192
[26] Thurner B, Roder C, Dieckmann D, Heuer M, Kru M, Glar
A, Keikavoussi P, Kampgen E, Bender A, Schuler G (1999) Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 223: 1-15
[27] de Vries IJ, Eggert AA, Scharenborg NM, Visrs JL, Lesterhuis
WJ, Boerman OC, Punt CJ, Adema GJ, Figdor CG (2002) Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother 25: 429-439
[28] Wojas K, Tabarkiewicz J, Rolinski J (2003) Dendritic cells in
养生讲座cancer immunotherapy - a short review. Folia Morphol 62: 317-318
Human dendritic cells in culture29嘴角痣
